Medtronic announces board appointments and shareholder value creation initiatives to advance strategic priorities

Experienced executives john groetelaars and bill jellison appointed to the board of directors board forms new growth and operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation plan to host investor day in 2026 initiatives follow constructive engagement with elliott management galway, ireland , aug. 19, 2025 /prnewswire/ -- medtronic plc (nyse: mdt), a global leader in healthcare technology, today announced the medtronic board of directors has appointed john groetelaars and bill jellison as independent directors, effective immediately. consistent with the company's commitment to shareholder value creation, and to provide enhanced focus and urgency around medtronic's ongoing strategic portfolio management, operational improvement and capital allocation, the board has formed the following special committees to align our governance with existing management focus areas and workstreams:  the growth committee will be responsible for guiding the evaluation and execution of growth-accretive tuck-in m&a, organic r&d investments, and potential divestitures, including the continued execution of the recently announced plan to separate its diabetes business.
MDT Ratings Summary
MDT Quant Ranking